Targeting Endothelial Cell Mitochondrial Quality Control in PAH

Mahin Gadkari^{1

2}, Karthik Suresh¹

Affiliations

¹ Department of Pulmonary Critical Care Medicine (M.G., K.S.), Johns Hopkins University School of Medicine, Baltimore, MD.
² Department of Chemical and Biomolecular Engineering (M.G.), Johns Hopkins University School of Medicine, Baltimore, MD.

Editorial

Mahin Gadkari et al. Circ Res. 2025.

. 2025 Jan 17;136(2):209-210.

doi: 10.1161/CIRCRESAHA.124.325940. Epub 2025 Jan 16.

Mahin Gadkari^{1

2}, Karthik Suresh¹

¹ Department of Pulmonary Critical Care Medicine (M.G., K.S.), Johns Hopkins University School of Medicine, Baltimore, MD.
² Department of Chemical and Biomolecular Engineering (M.G.), Johns Hopkins University School of Medicine, Baltimore, MD.

No abstract available

Keywords: Editorials; endothelial cells; mitochondrial diseases; pulmonary arterial hypertension; vascular diseases.

Conflict of interest statement

None.

Endothelial FUNDC1 Deficiency Drives Pulmonary Hypertension.
Pei Y, Ren D, Yin Y, Shi J, Ai Q, Hao W, Luo X, Zhang C, Zhao Y, Bai C, Zhu L, Wang Q, Li S, Zhang Y, Lu J, Liu L, Zhou L, Wu Y, Weng Y, Jing Y, Lu C, Cui Y, Zheng H, Li Y, Chen G, Hu G, Chen Q, Liao X. Pei Y, et al. Circ Res. 2025 Jan 17;136(2):e1-e19. doi: 10.1161/CIRCRESAHA.124.325156. Epub 2024 Dec 10. Circ Res. 2025. PMID: 39655444